Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension (NDLS) versus Conventional Docetaxel as Neoadjuvant and Adjuvant Therapy for Primary Operable Breast Cancer.

Revathi Badiginchala,Palanki Satya Dattatreya,Attili Venkata Satya Suresh,Sharanabasappa Somanath Nirni,Vindhya Vasini Andra,Deepak Bunger,Alok Chaturvedi

OncoTargets and therapy（2023）

引用 0|浏览2

暂无评分

摘要

NDLS-based neo/adjuvant chemotherapy was efficacious in the treatment of primary operable breast cancer and showed comparable pCR, ORR, DFS and OS rates versus conventional docetaxel. NDLS was better tolerated than conventional docetaxel.

查看译文

关键词

NDLS,breast cancer,docetaxel,nanosomal docetaxel lipid suspension,operable

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要